JP5300233B2 - 皮膚化粧料 - Google Patents
皮膚化粧料 Download PDFInfo
- Publication number
- JP5300233B2 JP5300233B2 JP2007239675A JP2007239675A JP5300233B2 JP 5300233 B2 JP5300233 B2 JP 5300233B2 JP 2007239675 A JP2007239675 A JP 2007239675A JP 2007239675 A JP2007239675 A JP 2007239675A JP 5300233 B2 JP5300233 B2 JP 5300233B2
- Authority
- JP
- Japan
- Prior art keywords
- action
- extract
- skin
- production
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 117
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 53
- 230000004130 lipolysis Effects 0.000 claims abstract description 40
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 31
- 239000002260 anti-inflammatory agent Substances 0.000 claims abstract description 26
- 229940121363 anti-inflammatory agent Drugs 0.000 claims abstract description 25
- 239000004480 active ingredient Substances 0.000 claims abstract description 22
- 230000002401 inhibitory effect Effects 0.000 claims description 141
- 238000004519 manufacturing process Methods 0.000 claims description 117
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 109
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 97
- 230000009471 action Effects 0.000 claims description 80
- 210000003491 skin Anatomy 0.000 claims description 73
- 230000001737 promoting effect Effects 0.000 claims description 70
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 44
- 238000006243 chemical reaction Methods 0.000 claims description 37
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims description 35
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 claims description 35
- 230000006378 damage Effects 0.000 claims description 34
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 32
- 208000010110 spontaneous platelet aggregation Diseases 0.000 claims description 29
- 102000002268 Hexosaminidases Human genes 0.000 claims description 28
- 108010000540 Hexosaminidases Proteins 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 27
- 108010003272 Hyaluronate lyase Proteins 0.000 claims description 26
- 102000009066 Hyaluronoglucosaminidase Human genes 0.000 claims description 26
- 102100030944 Protein-glutamine gamma-glutamyltransferase K Human genes 0.000 claims description 26
- 210000005175 epidermal keratinocyte Anatomy 0.000 claims description 26
- 229960002773 hyaluronidase Drugs 0.000 claims description 26
- 108010058734 transglutaminase 1 Proteins 0.000 claims description 26
- 230000002087 whitening effect Effects 0.000 claims description 25
- 230000001076 estrogenic effect Effects 0.000 claims description 23
- 238000011084 recovery Methods 0.000 claims description 23
- 239000000883 anti-obesity agent Substances 0.000 claims description 21
- 229940125710 antiobesity agent Drugs 0.000 claims description 21
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 20
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 20
- 230000005779 cell damage Effects 0.000 claims description 19
- 208000037887 cell injury Diseases 0.000 claims description 19
- 102000003390 tumor necrosis factor Human genes 0.000 claims description 12
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 8
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 7
- 230000003579 anti-obesity Effects 0.000 claims description 6
- 230000012010 growth Effects 0.000 claims description 2
- 241001412225 Firmiana simplex Species 0.000 claims 6
- 230000003078 antioxidant effect Effects 0.000 abstract description 27
- 239000003963 antioxidant agent Substances 0.000 abstract description 25
- 235000013305 food Nutrition 0.000 abstract description 19
- 238000002360 preparation method Methods 0.000 abstract description 7
- 244000002639 Delonix regia Species 0.000 abstract description 4
- 241001249608 Delonix Species 0.000 abstract description 3
- 238000005282 brightening Methods 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 description 78
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 67
- 239000000523 sample Substances 0.000 description 65
- 238000012360 testing method Methods 0.000 description 53
- 238000002835 absorbance Methods 0.000 description 52
- 239000012488 sample solution Substances 0.000 description 43
- 239000000243 solution Substances 0.000 description 42
- 230000002000 scavenging effect Effects 0.000 description 35
- 108010024636 Glutathione Proteins 0.000 description 33
- 229960003180 glutathione Drugs 0.000 description 33
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 30
- 239000000469 ethanolic extract Substances 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 238000000605 extraction Methods 0.000 description 26
- 239000002609 medium Substances 0.000 description 25
- 230000000694 effects Effects 0.000 description 24
- 230000005764 inhibitory process Effects 0.000 description 24
- 235000006708 antioxidants Nutrition 0.000 description 23
- 230000035755 proliferation Effects 0.000 description 22
- 238000011282 treatment Methods 0.000 description 21
- 230000009759 skin aging Effects 0.000 description 20
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 18
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 17
- 239000001301 oxygen Substances 0.000 description 17
- 229910052760 oxygen Inorganic materials 0.000 description 17
- 102000004190 Enzymes Human genes 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 16
- 229940088598 enzyme Drugs 0.000 description 16
- 206010061218 Inflammation Diseases 0.000 description 14
- 230000007423 decrease Effects 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 239000000839 emulsion Substances 0.000 description 14
- 230000004054 inflammatory process Effects 0.000 description 14
- 230000002265 prevention Effects 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 244000236655 Diospyros kaki Species 0.000 description 11
- -1 lipid peroxides Chemical class 0.000 description 11
- 230000006433 tumor necrosis factor production Effects 0.000 description 11
- 102000008186 Collagen Human genes 0.000 description 10
- 108010035532 Collagen Proteins 0.000 description 10
- 229920001436 collagen Polymers 0.000 description 10
- 230000006872 improvement Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000012258 culturing Methods 0.000 description 9
- 229960001340 histamine Drugs 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 206010003210 Arteriosclerosis Diseases 0.000 description 8
- 230000032683 aging Effects 0.000 description 8
- 208000011775 arteriosclerosis disease Diseases 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 238000007796 conventional method Methods 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 229930014626 natural product Natural products 0.000 description 8
- 239000002953 phosphate buffered saline Substances 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 102000004142 Trypsin Human genes 0.000 description 7
- 108090000631 Trypsin Proteins 0.000 description 7
- 230000008030 elimination Effects 0.000 description 7
- 238000003379 elimination reaction Methods 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 208000027866 inflammatory disease Diseases 0.000 description 7
- 239000012588 trypsin Substances 0.000 description 7
- 230000037303 wrinkles Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 235000011511 Diospyros Nutrition 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 208000012641 Pigmentation disease Diseases 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 210000002510 keratinocyte Anatomy 0.000 description 6
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 6
- 230000019612 pigmentation Effects 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 6
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 5
- 235000008597 Diospyros kaki Nutrition 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 235000015872 dietary supplement Nutrition 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 210000002615 epidermis Anatomy 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 210000002540 macrophage Anatomy 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 239000012086 standard solution Substances 0.000 description 5
- 230000001629 suppression Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 108010076876 Keratins Proteins 0.000 description 4
- 102000011782 Keratins Human genes 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 208000001145 Metabolic Syndrome Diseases 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 4
- 206010050661 Platelet aggregation inhibition Diseases 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 210000001789 adipocyte Anatomy 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 229940011871 estrogen Drugs 0.000 description 4
- 239000000262 estrogen Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000021588 free fatty acids Nutrition 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- 229920006008 lipopolysaccharide Polymers 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 4
- 239000012264 purified product Substances 0.000 description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 239000013638 trimer Substances 0.000 description 4
- 230000037373 wrinkle formation Effects 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 208000009137 Behcet syndrome Diseases 0.000 description 3
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 3
- 208000002177 Cataract Diseases 0.000 description 3
- 102000029816 Collagenase Human genes 0.000 description 3
- 108060005980 Collagenase Proteins 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- 231100000002 MTT assay Toxicity 0.000 description 3
- 238000000134 MTT assay Methods 0.000 description 3
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 201000004681 Psoriasis Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 229960002424 collagenase Drugs 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 230000037336 dry skin Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 230000037311 normal skin Effects 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000001626 skin fibroblast Anatomy 0.000 description 3
- 230000004215 skin function Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229940054269 sodium pyruvate Drugs 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000018185 Betula X alpestris Nutrition 0.000 description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 230000005778 DNA damage Effects 0.000 description 2
- 231100000277 DNA damage Toxicity 0.000 description 2
- 206010012442 Dermatitis contact Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- 240000008620 Fagopyrum esculentum Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 201000011152 Pemphigus Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000026062 Tissue disease Diseases 0.000 description 2
- 235000010724 Wisteria floribunda Nutrition 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000001668 ameliorated effect Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 208000010247 contact dermatitis Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000000066 endothelium dependent relaxing factor Substances 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000004299 exfoliation Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940014041 hyaluronate Drugs 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000007102 metabolic function Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 201000001976 pemphigus vulgaris Diseases 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 235000012045 salad Nutrition 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000004003 subcutaneous fat Anatomy 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 108010021724 tonin Proteins 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000234270 Amaryllidaceae Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241001131796 Botaurus stellaris Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- XUSYGBPHQBWGAD-PJSUUKDQSA-N Carnosol Chemical compound CC([C@@H]1C2)(C)CCC[C@@]11C(=O)O[C@@H]2C2=C1C(O)=C(O)C(C(C)C)=C2 XUSYGBPHQBWGAD-PJSUUKDQSA-N 0.000 description 1
- MMFRMKXYTWBMOM-UHFFFAOYSA-N Carnosol Natural products CCc1cc2C3CC4C(C)(C)CCCC4(C(=O)O3)c2c(O)c1O MMFRMKXYTWBMOM-UHFFFAOYSA-N 0.000 description 1
- 244000025596 Cassia laevigata Species 0.000 description 1
- 235000006693 Cassia laevigata Nutrition 0.000 description 1
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 description 1
- 101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241000218218 Ficus <angiosperm> Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- BBBXWRGITSUJPB-YUMQZZPRSA-N Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O BBBXWRGITSUJPB-YUMQZZPRSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 101710184006 Glutaminase 1 Proteins 0.000 description 1
- 108010053070 Glutathione Disulfide Proteins 0.000 description 1
- 108010063907 Glutathione Reductase Proteins 0.000 description 1
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000193159 Hathewaya histolytica Species 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 101000741967 Homo sapiens Presequence protease, mitochondrial Proteins 0.000 description 1
- 229940122393 Hyaluronidase inhibitor Drugs 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 229940084845 Metalloproteinase-1 inhibitor Drugs 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 101000648740 Mus musculus Tumor necrosis factor Proteins 0.000 description 1
- NULAJYZBOLVQPQ-UHFFFAOYSA-N N-(1-naphthyl)ethylenediamine Chemical compound C1=CC=C2C(NCCN)=CC=CC2=C1 NULAJYZBOLVQPQ-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 206010030247 Oestrogen deficiency Diseases 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000120647 Osbeckia Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 239000007990 PIPES buffer Substances 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 229940126902 Phlorizin Drugs 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 102100038632 Presequence protease, mitochondrial Human genes 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 244000305267 Quercus macrolepis Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241001237745 Salamis Species 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000208000 Striga Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 108060008539 Transglutaminase Proteins 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 235000019209 bilberry extract Nutrition 0.000 description 1
- 229940102480 bilberry extract Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000004654 carnosol Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000025084 cell cycle arrest Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000009134 cell regulation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 1
- 108010067755 dinitrophenyl-bovine serum albumin Proteins 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960001008 heparin sodium Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- VNYSSYRCGWBHLG-AMOLWHMGSA-N leukotriene B4 Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O VNYSSYRCGWBHLG-AMOLWHMGSA-N 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000010813 municipal solid waste Substances 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 229940027779 persimmon extract Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-GHRYLNIYSA-N phlorizin Chemical compound O[C@@H]1[C@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-GHRYLNIYSA-N 0.000 description 1
- 235000019139 phlorizin Nutrition 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229960002244 promethazine hydrochloride Drugs 0.000 description 1
- XXPDBLUZJRXNNZ-UHFFFAOYSA-N promethazine hydrochloride Chemical compound Cl.C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 XXPDBLUZJRXNNZ-UHFFFAOYSA-N 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002683 reaction inhibitor Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033904 relaxation of vascular smooth muscle Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 235000015175 salami Nutrition 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000012046 side dish Nutrition 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- NZHGWWWHIYHZNX-CSKARUKUSA-N tranilast Chemical compound C1=C(OC)C(OC)=CC=C1\C=C\C(=O)NC1=CC=CC=C1C(O)=O NZHGWWWHIYHZNX-CSKARUKUSA-N 0.000 description 1
- 229960005342 tranilast Drugs 0.000 description 1
- 102000003601 transglutaminase Human genes 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 239000008256 whipped cream Substances 0.000 description 1
- 210000000636 white adipocyte Anatomy 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
〔抗酸化剤,抗炎症剤,抗老化剤,抗肥満剤,脂肪分解促進剤,美白剤〕
本発明の抗酸化剤、抗炎症剤、抗老化剤、抗肥満剤、脂肪分解促進剤又は美白剤は、鳳凰木からの抽出物を有効成分として含有する。
鳳凰木からの抽出物は、スーパーオキサイド消去作用、過酸化水素消去作用、グルタチオン産生促進作用、一酸化窒素産生抑制作用、TNF−α産生抑制作用、ヒアルロニダーゼ阻害作用、ヘキソサミニダーゼ遊離抑制作用、血小板凝集抑制作用、マトリックスメタロプロテアーゼ−1阻害作用、エストロゲン様作用、表皮角化細胞増殖促進作用、紫外線照射によるダメージ回復作用、過酸化水素による細胞障害抑制作用、トランスグルタミナーゼ−1産生促進作用、メイラード反応阻害作用又は脂肪分解促進作用を有しており、皮膚に適用した場合の使用感と安全性とに優れているため、皮膚化粧料に配合するのに好適である。
鳳凰木からの抽出物は、スーパーオキサイド消去作用、過酸化水素消去作用、グルタチオン産生促進作用、一酸化窒素産生抑制作用、TNF−α産生抑制作用、ヒアルロニダーゼ阻害作用、ヘキソサミニダーゼ遊離抑制作用、血小板凝集抑制作用、マトリックスメタロプロテアーゼ−1阻害作用、エストロゲン様作用、表皮角化細胞増殖促進作用、紫外線照射によるダメージ回復作用、過酸化水素による細胞障害抑制作用、トランスグルタミナーゼ−1産生促進作用、メイラード反応阻害作用又は脂肪分解促進作用を有しており、消化管で消化されるようなものではないことが確認されており、安全性にも優れているため、飲食品に配合するのに好適である。
鳳凰木の葉部の粗粉砕物100gに抽出溶媒1000mLを加え、穏やかに攪拌しながら80℃にて2時間保ち、熱時濾過した。得られた抽出液を40℃で減圧下にて濃縮し、減圧乾燥機で乾燥して鳳凰木葉部抽出物を得た(試料1〜3)。抽出溶媒として、水、50容量%エタノール(水とエタノールとの容量比1:1)、80容量%エタノール(水とエタノールとの容量比1:4)を用いたときの各抽出物の収率を表1に示す。
製造例1により得られた鳳凰木葉部抽出物(試料1〜3)について、以下のようにしてスーパーオキサイド消去作用を試験した。
上記式において、Aは「酵素溶液添加・試料溶液添加時の吸光度」を、Bは「酵素溶液無添加・試料溶液添加時の吸光度」を、Cは「酵素溶液添加・試料溶液無添加時の吸光度」を、Dは「酵素溶液無添加・試料溶液無添加時の吸光度」を示す。
上記試験の結果を表2に示す。
製造例1により得られた鳳凰木葉部抽出物(試料1〜3)について、以下のようにして過酸化水素消去作用を試験した。
上記式において、Aは「過酸化水素標準溶液添加・試料溶液添加時の吸光度」を、Bは「過酸化水素標準溶液無添加・試料溶液添加時の吸光度」を、Cは「過酸化水素標準溶液添加・試料溶液無添加時の吸光度」を表し、Dは「過酸化水素標準溶液無添加・試料溶液無添加時の吸光度」を表す。
上記試験の結果を表3に示す。
製造例1により得られた鳳凰木葉部80容量%エタノール抽出物(試料3)について、以下のようにしてグルタチオン産生促進作用を試験した。
上記式において、Aは「試料無添加時の細胞中における総タンパク量あたりのグルタチオン量」を、Bは「試料添加時の細胞中における総タンパク量あたりのグルタチオン量」を表す。
上記試験の結果を表4に示す。
製造例1により得られた鳳凰木葉部80容量%エタノール抽出物(試料3)について、以下のようにして一酸化窒素(NO)産生抑制作用を試験した。
式中、Aは「試料無添加時の吸光度」を表し、Bは「試料無添加時のブランクの吸光度」を表し、Cは「試料添加時の吸光度」を表し、Dは「試料添加時のブランクの吸光度」を表す。
結果を表5に示す。
製造例1により得られた鳳凰木葉部80容量%エタノール抽出物(試料3)について、以下のようにして腫瘍壊死因子(TNF−α)産生抑制作用を試験した。
式中、Aは「試料溶液添加時のTNF−α量」を表し、Bは「試料溶液無添加時のTNF−α量」を表す。
結果を表6に示す。
製造例1により得られた鳳凰木葉部抽出物(試料1〜3)について、下記のようにしてヒアルロニダーゼ阻害作用を試験した。
式中、Aは「試料添加・酵素溶液添加時の波長585nmにおける吸光度」を表し、Bは「試料添加・酵素溶液無添加時の波長585nmにおける吸光度」を表し、Cは「試料無添加・酵素溶液添加時の波長585nmにおける吸光度」を表し、Dは「試料無添加・酵素溶液無添加時の波長585nmにおける吸光度」を表す。
結果を表7に示す。
製造例1により得られた鳳凰木葉部抽出物(試料1〜3)について、以下のようにしてヘキソサミニダーゼ遊離抑制作用を試験した。
式中、Aは「試料無添加時の波長415nmにおける吸光度」を表し、Bは「試料添加時の波長415nmにおける吸光度」を表し、Cは「試料添加・p−NAG無添加時の波長415nmにおける吸光度」を表す。
結果を表8に示す。
製造例1により得られた鳳凰木葉部抽出物(試料1〜3)について、以下のようにして血小板凝集抑制作用を試験した。
採血したウサギの血液にヘパリンナトリウム注射液(日本薬局方)を1/10量加えて遠心分離(180×g、10分、室温)して、血小板浮遊液(Platelet Rich Plasma,P.R.P.)を得た。
次に、血小板浮遊液(P.R.P.)223μLに200mmo1/Lの塩化カルシウム溶液1μLを加え、37℃で1分間反応した。これに試料溶液1μLを加え、さらに2分間反応し、撹拌子を入れて1分間撹絆した後、コラーゲン溶液25μLを添加して、37℃で10分間反応した後の血小板凝集率を測定した。別に、コントロールとして試料溶液の代わりに試料溶液の溶媒を添加した以外は、上記と同様に操作して血小板凝集率を測定した。得られた結果から、下記式により血小板凝集抑制率(%)を算出した。
式中、Aは「コントロールの血小板凝集率」を表し、Bは「試料添加時の血小板凝集率」を表す。
結果を表9に示す。
製造例1により得られた鳳凰木葉部抽出物(試料1〜3)について、以下のようにしてマトリックスメタロプロテアーゼ−1(MMP−1)阻害作用を試験した。
式中、Aは「試料無添加・酵素添加時の吸光度」を表し、Bは「試料無添加・酵素無添加時の吸光度」を表し、Cは「試料添加・酵素添加時の吸光度」を表し、Dは「試料添加・酵素無添加時の吸光度」を表す。
結果を表10に示す。
製造例1により得られた鳳凰木葉部80容量%エタノール抽出物(試料3)について、以下のようにしてエストロゲン様作用を試験した。
上記式において、Aは「試料溶液添加時の吸光度」を表し、Bは「試料溶液無添加時の吸光度」を表す。
上記試験の結果を表11に示す。
製造例1により得られた鳳凰木葉部80容量%エタノール抽出物(試料3)について、以下のようにして表皮角化細胞増殖作用を試験した。
上記式において、Aは「試料添加時の吸光度」を表し、Bは「試料無添加の吸光度」を表す。
上記試験の結果を表12に示す。
製造例1によれ得られた鳳凰木葉部80容量%エタノール抽出物(試料3)について、以下のようにして紫外線UV−Bによるダメージからの回復作用を試験した。
式中、Aは「UV−Bを照射していない細胞での吸光度」を表し、Bは「UV−Bを照射し試料溶液を添加していない細胞での吸光度」を表し、Cは「UV−Bを照射し試料溶液を添加した細胞」での吸光度を表す。
結果を表13に示す。
製造例1により得られた鳳凰木葉部80容量%エタノール抽出物(試料3)について、以下のようにして過酸化水素による細胞障害抑制作用を試験した。
上記式において、Aは「試料溶液添加・過酸化水素溶液添加時の吸光度」を、Bは「試料溶液無添加・過酸化水素溶液添加時の吸光度」を、Cは「試料溶液無添加・過酸化水素溶液無添加時の吸光度」を表す。
結果を表14に示す。
製造例1により得られた鳳凰木葉部80容量%エタノール抽出物(試料3)について、以下のようにしてトランスグルタミナーゼ−1産生促進作用を試験した。
式中、Aは「試料添加時の波長405nmにおける吸光度」を表し、Bは「試料無添加時の波長405nmにおける吸光度」を表す。
試験結果を表15に示す。
製造例1により得られた鳳凰木葉部80容量%エタノール抽出物(試料3)について、以下のようにしてメイラード反応抑制作用を試験した。
式中、Aは「試料添加時の二量体及び三量体のNet intensityの和」を表し、Bは「コントロールの二量体及び三量体のNet intensityの和」を表し、Cは「ブランクの二量体及び三量体のNet intensityの和」を表す。
結果を表16に示す。
製造例1により得られた鳳凰木葉部80容量%エタノール抽出物(試料3)について、以下のようにして脂肪分解促進作用を試験した。
ウイスター系雄性ラット(8週齢)7匹をエーテル麻酔にかけ、麻酔下で断頭により放血致死させた。副睾丸上の脂肪組織を切り出し、37℃に保温した生理食塩水中で組織をハサミで細かく切った。組織小片を小型の三角フラスコに入れ、これに10mLの緩衝液A(119mmol/Lの塩化ナトリウム、4.7mmol/Lの塩化カリウム、2.6mmol/Lの塩化カルシウム、1.2mmol/Lのリン酸二水素カリウム、1.2mmol/Lの硫酸マグネシウム、32.3mmol/LのHEPES(pH7.4)、20mg/mLのウシ血清アルブミン、及び2mmol/Lのグルコース)に溶解した10mgのコラゲナーゼを入れて1時間37℃で攪拌(100rpm/min)しながら反応させた。
上記のようにして調製した脂肪細胞液を96ウェルプレートに1ウェルあたり90μLずつ播種し、試料溶液を各ウェルに10μLずつ添加して、1.5時間インキュベートした。その後、各ウェルから5μLずつ採取して、遊離した脂肪酸量をNEFA−Cテストワコー(和光純薬工業社製)により測定した。得られた測定結果から、下記式により脂肪分解促進率(%)を算出した。
式中、Aは「試料添加時の遊離脂肪酸量」を表し、Bは「試料無添加時の遊離脂肪酸量」を表す。
結果を表17に示す。
製造例1により得られた鳳凰木葉部80容量%エタノール抽出物(試料3)を配合した乳液(以下「実施例乳液」という)を常法に従って調製した。実施例乳液の組成を以下に示す。
セチルアルコール 0.5g
ミツロウ 2.0g
オレイン酸ポリオキシエチレンソルビタン(10E.O.) 1.0g
モノステアリン酸グリセリル 1.0g
ヒアルロン酸 0.1g
プロピレングリコール 5.0g
エタノール 3.0g
パラオキシ安息香酸メチル 0.3g
香料 0.03g
精製水 (全量を100gとする)
塗布試験:各被験者の顔の右半分には実施例乳液を、左半分には比較例乳液を、朝夕各1回、30日間塗布させた。
塗布試験終了後、シルフロ(FLEXICL DEVELOPMENTS LTD.社製)によるレプリカ法を用いて顔のレプリカをとり、50倍の顕微鏡で皮紋の状態及び角質剥離の状態を観察し、下記表18に示す評価基準で肌の状態を判定した。
判定結果を表19に示す。
使用感と肌への効果とについて、実施例乳液と比較例乳液とを比較した優劣を被験者全員に質問した。
回答の集計結果を表20に示す。
これらのことから、鳳凰木葉部抽出物を配合した皮膚化粧料が、皮膚の老化防止・改善作用(肌荒れ改善作用)を有するとともに、皮膚に適用した場合の使用感と安全性とに優れていることが確認された。
下記組成の乳液を常法により製造した。
鳳凰木葉部80%エタノール抽出物(製造例1) 1.0g
ホホバオイル 4.0g
オリーブオイル 2.0g
スクワラン 2.0g
セタノール 2.0g
モノステアリン酸グリセリル 2.0g
ポリオキシエチレンセチルエーテル(20E.O.) 2.5g
オレイン酸ポリオキシエチレンソルビタン(20E.O.) 2.0g
1,3−ブチレングリコール 3.0g
パラオキシ安息香酸メチル 0.15g
香料 0.05g
精製水 残部(全量を100gとする)
下記組成の化粧水を常法により製造した。
鳳凰木葉部80%エタノール抽出物(製造例1) 2.2g
グリセリン 3.0g
1,3−ブチレングリコール 3.0g
オレイン酸ポリオキシエチレンソルビタン(20E.O.) 0.5g
パラオキシ安息香酸メチル 0.15g
クエン酸 0.1g
クエン酸ソーダ 0.1g
香料 0.05g
精製水 残部(全量を100gとする)
下記組成のクリームを常法により製造した。
鳳凰木葉部80%エタノール抽出物(製造例1) 1.1g
流動パラフィン 5.0g
サラシミツロウ 4.0g
セタノール 3.0g
スクワラン 10.0g
ラノリン 2.0g
ステアリン酸 1.0g
オレイン酸ポリオキシエチレンソルビタン(20E.O.) 1.5g
モノステアリン酸グリセリル 3.0g
1,3−ブチレングリコール 6.0g
香料 0.1g
精製水 残部(全量を100gとする)
下記組成のパックを常法により製造した。
鳳凰木葉部80%エタノール抽出物(製造例1) 5.0g
ポリビニルアルコール 15.0g
ポリエチレングリコール 3.0g
プロピレングリコール 7.0g
エタノール 10.0g
パラオキシ安息香酸エチル 0.05g
香料 0.05g
精製水 残部(全量を100gとする)
下記の混合物を打錠して、錠剤状の栄養補助食品を製造した。
鳳凰木葉部80%エタノール抽出物(製造例1) 50質量部
粉糖(ショ糖) 188質量部
グリセリン脂肪酸エステル 12質量部
下記の混合物を顆粒状にして、栄養補助食品を製造した。
鳳凰木葉部80%エタノール抽出物(製造例1) 50質量部
ビートオリゴ糖 1000質量部
ビタミンC 167質量部
ステビア抽出物 10質量部
Claims (8)
- 水、低級脂肪族アルコール又はこれらの混合液を用いて抽出された鳳凰木の葉部からの抽出物を有効成分として含有することを特徴とする抗炎症剤。
- 前記抽出物が、一酸化窒素(NO)産生抑制作用、腫瘍壊死因子(TNF−α)産生抑制作用、ヒアルロニダーゼ阻害作用、ヘキソサミニダーゼ遊離抑制作用及び血小板凝集抑制作用からなる群より選ばれる1種又は2種以上の作用を有することを特徴とする請求項1に記載の抗炎症剤。
- 水、低級脂肪族アルコール又はこれらの混合液を用いて抽出された鳳凰木の葉部からの抽出物を有効成分として含有することを特徴とする抗老化剤。
- 前記抽出物が、マトリックスメタロプロテアーゼ−1(MMP−1)阻害作用、エストロゲン様作用、表皮角化細胞増殖促進作用、紫外線(UV−B)照射によるダメージ回復作用、過酸化水素による細胞障害抑制作用、トランスグルタミナーゼ−1産生促進作用及びメイラード反応阻害作用からなる群より選ばれる1種又は2種以上の作用を有することを特徴とする請求項3に記載の抗老化剤。
- 水、低級脂肪族アルコール又はこれらの混合液を用いて抽出された鳳凰木の葉部からの抽出物を有効成分として含有することを特徴とする抗肥満剤。
- 水、低級脂肪族アルコール又はこれらの混合液を用いて抽出された鳳凰木の葉部からの抽出物を有効成分として含有することを特徴とする脂肪分解促進剤。
- 水、低級脂肪族アルコール又はこれらの混合液を用いて抽出された鳳凰木の葉部からの抽出物を有効成分として含有することを特徴とする美白剤。
- 水、低級脂肪族アルコール又はこれらの混合液を用いて抽出された鳳凰木の葉部からの抽出物を配合したことを特徴とする抗炎症、抗老化、抗肥満又は美白の用途に用いられる皮膚化粧料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007239675A JP5300233B2 (ja) | 2007-09-14 | 2007-09-14 | 皮膚化粧料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007239675A JP5300233B2 (ja) | 2007-09-14 | 2007-09-14 | 皮膚化粧料 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009067747A JP2009067747A (ja) | 2009-04-02 |
JP5300233B2 true JP5300233B2 (ja) | 2013-09-25 |
Family
ID=40604390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007239675A Active JP5300233B2 (ja) | 2007-09-14 | 2007-09-14 | 皮膚化粧料 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5300233B2 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101068808B1 (ko) | 2008-10-21 | 2011-10-04 | 인하대학교 산학협력단 | 봉황목 추출물을 유효성분으로 함유하는 미백용 조성물 |
JP2013023474A (ja) * | 2011-07-21 | 2013-02-04 | Pias Arise Kk | 美白剤 |
JP6502011B2 (ja) * | 2013-10-07 | 2019-04-17 | 三省製薬株式会社 | グルタチオン産生促進剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4163631B2 (ja) * | 2003-01-28 | 2008-10-08 | 森永製菓株式会社 | 無辛味品種トウガラシの発酵組成物及びその利用 |
JP4644787B2 (ja) * | 2003-08-19 | 2011-03-02 | 沖縄県 | リパーゼ阻害活性且つ抗酸化性を有する抗肥満剤 |
JP2006321730A (ja) * | 2005-05-17 | 2006-11-30 | Maruzen Pharmaceut Co Ltd | 抗酸化剤及び抗老化剤、並びに皮膚化粧料及び飲食物 |
KR100803577B1 (ko) * | 2005-11-30 | 2008-02-15 | (주)아모레퍼시픽 | 이카린의 가수분해물을 함유하는 화장료용 조성물 |
JP2007210962A (ja) * | 2006-02-10 | 2007-08-23 | Maruzen Pharmaceut Co Ltd | 抗酸化剤及び抗老化剤、並びに皮膚化粧料及び美容用飲食品 |
JP5224648B2 (ja) * | 2006-02-21 | 2013-07-03 | 丸善製薬株式会社 | 抗皮膚炎症剤、美白剤及び抗皮膚老化剤 |
-
2007
- 2007-09-14 JP JP2007239675A patent/JP5300233B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2009067747A (ja) | 2009-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6670166B2 (ja) | 化粧料 | |
JP6969067B2 (ja) | 抗炎症剤、抗老化剤および美白剤 | |
JP2009046465A (ja) | 皮膚化粧料及び飲食品 | |
JP5162174B2 (ja) | 育毛剤及び抗肥満剤 | |
JP5512067B2 (ja) | 皮膚化粧料 | |
JP6055667B2 (ja) | コラーゲン産生促進剤 | |
JP5300233B2 (ja) | 皮膚化粧料 | |
JP4672269B2 (ja) | 抗老化剤、血小板凝集抑制剤、抗酸化剤、抗アレルギー剤、皮膚化粧料及び飲食品 | |
JP5220346B2 (ja) | 皮膚化粧料 | |
JP5534654B2 (ja) | 抗炎症剤 | |
JP2016079154A (ja) | 皮膚化粧料、頭髪化粧料および飲食品 | |
JP5307366B2 (ja) | 育毛剤 | |
JP4889071B2 (ja) | 皮膚化粧料および飲食品 | |
JP5419258B2 (ja) | 化粧料 | |
JP5058414B2 (ja) | 皮膚化粧料並びに飲食品 | |
JP4748926B2 (ja) | 皮膚化粧料及び飲食品 | |
JP7361412B2 (ja) | 皮膚化粧料、頭髪化粧料および飲食品 | |
JP6375100B2 (ja) | 抗老化剤、美白剤、皮膚化粧料および飲食品 | |
JP2019202967A (ja) | 抗老化用組成物、抗老化用皮膚化粧料および抗老化用飲食品 | |
JP6981685B2 (ja) | 皮膚化粧料、頭髪化粧料および飲食品 | |
JP6993628B2 (ja) | 皮膚化粧料、頭髪化粧料および飲食品 | |
KR20180072381A (ko) | 투탕카멘 완두 추출물을 포함하는 피부 상태 개선용 조성물 | |
JP2016079155A (ja) | 皮膚化粧料、頭髪化粧料および飲食品 | |
JP2024060053A (ja) | 糖化に起因した保湿機能低下の抑制剤、皮膚化粧料および飲食品 | |
JP5719882B2 (ja) | サイクリックAMP−ホスホジエステラーゼ活性阻害剤、エラスターゼ活性阻害剤、マトリックスメタロプロテアーゼ−1(MMP−1)活性阻害剤、マトリックスメタロプロテアーゼ−14(MMP−14)活性阻害剤、表皮角化細胞増殖促進剤、エストロゲン様作用剤、エンドセリン−1mRNA発現上昇抑制剤及びSCFmRNA発現上昇抑制剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100903 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120315 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121107 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121227 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130612 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130618 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5300233 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |